INTRODUCTION
The expression of ferritin, the major intracellular iron-storage protein, is thought to have two principal regulatory functions, which involve scavenging of intracellular iron and the attenuation of reactive oxygen species (ROS) formation. In the first, synthesis of ferritin subunits is triggered by a rise in the putative cellular labile iron pool (LIP) that is sensed and transduced by ironresponsive proteins (IRPs). In the second, ferritin transcription is modulated in response to factors that either raise or lower cellular growth-dependence on LIP. Thus oncogene suppression of ferritin expression purportedly raises the LIP and supports proliferation [1] [2] [3] [4] [5] [6] . On the other hand, cytokines, by promoting ferritin expression and thereby lowering the LIP, confer upon cells protection from invading pathogens and oxidative damage [7] [8] [9] [10] [11] .
Thus far, experimental support for the alleged role of ferritin in the control of LIP levels has been provided only by studies of heavy ferritin subunit (H-FT) overexpression. In these studies [12, 13] , expression of the H-FT gene mutated in the ironresponsive element enabled the iron-independent translation of H-FT. This strategy led to an increased expression of H-FT which, in turn, reduced the steady-state LIP levels and the ensuing ROS production, and increased resistance to ROS toxicity [13] . Furthermore, stable inducible transfection of HeLa cells with wild-type H-FT cDNA, but not with its ferroxidase mutant, led to a substantial reduction in the LIP [14] . This reduction was associated with up-regulation of IRP activity, transferrin-mediated iron uptake and resistance to ROS toxicity.
In the present study, we analysed the opposite situation, i.e. the functional consequences of H-FT repression in terms of its capacity to increase the LIP. For that purpose, we used transient transfection of cells with an antisense sequence against H-FT as a means to down-modulate expression of H-FT. The choice of antisense was made in order to manipulate ferritin in a specific manner, and independently of the iron status of the cells. The specificity of the antisense H-FT was confirmed by its inability to repress light ferritin subunit (L-FT). We used fluorescence detection of metals as a means to assess LIP [15] , and the oxidation of carboxydichlorodihydrofluorescin (carboxy-H # DCF) as a means to assess exogenously induced ROS production [16] . The levels of cell-surface expression of the transferrin receptor (TfR) served as a tool for confirming the iron-regulation capacity of LIP. Our results provide direct experimental support for the alleged roles of H-FT as a regulator of LIP and as an attenuating factor in the antioxidative cell response.
EXPERIMENTAL Materials
Calcein, calcein acetomethoxy, 2h-7h-carboxydichlorodihydrofluorescein-diacetate diacetoxymethyl ester (H # DCFDA-diAM) and fluorescein-β-galactosidase were obtained from Molecular Probes (Eugene, OR, U.S.A.), and Triton X-100 and the DOTAP lipid reagent were from Boehringer Mannheim. The following gifts were received : human H-FT cDNA and rabbit anti-human sera against placental and spleen ferritin from Professor H. Rosen and Professor A. M. Konijn respectively (Hadassah Medical School, Hebrew University), salicylaldehyde hydrazone from Professor Prem Ponka (McGill University, Montreal, Canada), mouse anti-(human H-FT) and anti-(human L-FT) monoclonal antibodies and recombinant human H-FT and L-FT from Dr Paolo Santambroggio (Dipartimento di Ricerca Biologica e Technologica, San Rafaelle Hospital, Milan, Italy), and the pRBG4 vector from Dr Israel Seckler (Faculty of Medicine, Ben Gurion University, Beer Sheva, Israel). Unless specified otherwise, all other chemicals were from Sigma or were of the best available grade.
Cells
Human erythroleukaemia K562 cells were grown as described in [17] .
Transient transfection of cells with antisense to ferritin mRNAs
A partial human H-FT cDNA sequence (residues 283-616 in human H-FT mRNA sequence, GenBank2 accession number L20941) was PCR-synthesized using the primers 5h-GGAACA-TGCTGAGAAACTG-3h (forward) and 5h-GGTGTGCTTGT-CAAAG-3h (reverse). An EcoRI recognition sequence, 5h-CCG-GAATTCC-3h, was added to the 5h of each primer and used for ligation in an antisense orientation between the promoter and the polyadenylated sequences of the cytomegalovirus in the pRBG4 vector [18] . The antisense orientation was verified by sequencing the insert and junction sequences. Transfection of pRBG4 with and without the H-FT antisense insert was done by the DOTAP method (Boehringer Mannheim) and assessed 24 h later.
Ferritin quantitation by ELISA
For ferritin determination, samples of approx. 400 000 cells were centrifuged, and the pellet was extracted at 4 mC for 15 min with 200 µl of buffer (10 mM Tris\HCl, pH 7.4, 150 mM NaCl, 0.3 % Triton X-100 and 0.25 % NaN $ ) containing an antiprotease cocktail (P-8340 ; Sigma) and 250 µM PMSF. The extract was centrifuged at 8500 g for 2 min at 4 mC, and the supernatant was analysed for protein content (bicinchoninic acid method ; Sigma). Immunoplates (Nunc, Roskilde, Denmark) were coated with mouse anti-(human H-FT) or mouse anti-(human L-FT) monoclonal antibodies (20 µg\ml in carbonate buffer, pH 9.6) and incubated for 1 h at 37 mC. The plates were then blocked with 3 % BSA in PBS for 2 h at room temperature. Subsequently, samples (2 µg of protein) and ferritin standards (0-1 ng of recombinant H-FT or L-FT) were dissolved in 3 % BSA and added to the plates for incubation of 1 h at 37 mC. Incubation (3 h at room temperature) with rabbit antisera against human placental ferritin (approx. 50 % anti-H-FT and 50 % anti-L-FT activity) or against human spleen ferritin (95 % anti-L-FT and 5 % anti-H-FT activity) was used for determination of H-FT and L-FT respectively. Rabbit IgG was detected by incubation with goat anti-rabbit antibodies coupled to β-galactosidase (Amersham International) for 1 h at 37 mC and then 1 h at room temperature. Fluorescence (λ excitation 488 nm ; λ emission 525 nm) of the fluorogenic substrate fluorescein-β-galactosidase was followed with time of incubation in a Fluostar II fluorescence plate reader (BMG LabTechnologies, GmBH, Offenburg, Germany) and quantified with the aid of calibration curves of normal rabbit IgG.
Assessment of RNA levels of H-FT and L7 by reverse transcriptase (RT)-PCR
Total RNA from K562 cells was isolated using Ultraspec RNA isolation reagent (Biotec Laboratories, Houston, TX, U.S.A.). RNA (1 µg) was reverse-transcribed and PCR amplified using the Titan One Step RT-PCR system according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany). Total RNA was added to the PCR mix (containing avian myeloblastosis virus RT, Taq and Pwo DNA polymerases and 40 units\µl RNase inhibitor) together with the following primer pairs. For human H-FT (GenBank2 accession number L20941) : forward, 5h-GCCAAATACTTTCTTCACC3h ; reverse, 5h-TTCATTATCACTGTCTCCC-3h. These primers spanned a 390 bp sequence between residues 365 and 754. For human L7 (an internal control, GenBank2 accession number X57958) : forward, 5h-GAAGAGAAGAAGAAGGAGG-3h ; reverse, 5h-GGTACATAGAAGTTGCCAG-3h. These primers spanned a 239 bp sequence between residues 50 and 288. Following RT at 50 mC for 30 min (terminated by heating for 2 min at 94 mC), touchdown-PCR was performed for 10 cycles using the following temperatures : denaturation for 1 min at 94 mC, annealing for 2 min at 65 mC, with a lowering increment of 2 mC per cycle, and elongation for 3 min at 68 mC. Thermocycling was then continued for up to 21 cycles as follows : denaturation for 30 s at 94 mC, annealing for 30 s at 45 mC, and elongation for 45 s (plus 5 s per cycle) at 68 mC. Samples were collected at cycles 16-21 following the touchdown-PCR. All RT-PCR reactions were performed by the Mastercycler thermocycler (Eppendorf, Hamburg, Germany). The samples were separated on a 1.6 % agarose gel containing the SYBR Gold nucleic acid stain (Molecular Probes) and photographed under UV light. The attenuance of samples taken from cycles 16-21 were within a linear range.
Immunofluorescence
Cells fixed in methanol and treated with 3 % BSA were incubated first with mouse monoclonal antibodies against human H-FT (20 µg\ml) and subsequently with FITC-conjugated antimouse IgG and 1 µg\ml 4,6-diamidino-2-phenylindole (DAPI). Samples of 10 µl were loaded on to a glass slide and examined in an Olympus IX70 (Tokyo, Japan) fluorescence microscope (λ excitation , 490 nm ; λ emission 520 nm). DAPI-labelling assisted us in confirming that the FITC staining was cell-associated. Images were processed by EPIX's (Buffalo Grove, IL, U.S.A.) XCAP Image Acquisition, Display, Processing and Analysis Software. Quantitation of the data was performed by the ImagePro Plus software (Media Cybernetics, Silver Spring, MD, U.S.A.).
LIP measurement and cell ROS production
LIP was measured by the calcein-based fluorescence method, as described previously [15] . ROS was determined in cells (10'\ml) loaded with 10 µM H # DCFDA-diAM for 20 min at 37 mC (based on the method described in [16] ), centrifuged, and resuspended in Hepes-buffered saline supplemented with hydroxyethyl-starchdeferoxamine (BioMedical Frontiers, Minneapolis, MN, U.S.A.) in order to prevent extracellular-metal-catalysed substrate oxidation. Tracing of H # O # (5 µM)-induced oxidation of the nonfluorescent carboxy-H # DCF to the fluorescent carboxy-DCF was carried out fluorimetically (λ excitation , 490 nm ; λ emission 520 nm) (PTI, South Brunswick, NJ, U.S.A.). Maximum fluorescence attained in the sample (F max ) was obtained by cell permeabilization with 0.5 % Triton X-100 and addition of fresh 1 mM ferrous ammonium sulphate and 1 mM H # O #. The rate of ROS formation was assessed by the amount of carboxy-DCF produced per second. The concentration of carboxy-DCF is given by :
Where F and F max are the fluorescence at any given time and the maximal fluorescence (both in relative units) respectively, and (carboxy-DCF) cmax is the concentration factor obtained by calibration with standard carboxy-DCF. The concentration of carboxy-DCF in the cells (carboxy-DCF) in was obtained from :
Where N C is the cell concentration in the cuvette (cells\ml) and V C is the volume of a single cell (ml\cell). Cells were counted in a Coulter counter and their volume obtained as described in [19] .
Cellular iron content.
Total cell iron was measured as described in [12] . 
of PBS. Triplicate aliquots (50 µl) were used for counting radioactivity in an aqueous Quicksafe A (Zinsser, Maidenhead, Berks., U.K.) fluid using a scintillation counter (Beckman, Irvine, CA, U.S.A.). Protein content was determined by the bicinchoninic acid method. Specific [&&Fe]transferrin uptake was obtained by subtracting the non-specific from the total counts for each time point. Cell surface TfR was measured as above, except that the cells were incubated at 4 mC and were not stripped.
RESULTS

Repression of ferritin subunits
Transfection of K562 cells with an antisense fragment reduced the cellular H-FT levels by approx. 50 % as compared with The relative changes in L7-normalized H-FT mRNA levels were calculated using densitometric analysis of bands of cycle 18, which were within the linear range of increase in luminosity against cycle number. MeanspS.D. of three independent experiments are shown. The mRNA density of the H-FT antisense-treated cells was significantly lower than that of the untreated cells (P 0.01).
Table 1 H-FT expression, LIP, pro-oxidant-induced ROS production and cellular iron content in K562 cells transiently transfected with H-FT AS
Cells were transfected using the DOTAP reagent, and assayed in parallel 24 h later for the indicated parameters. H-FT and L-FT expression were determined by the ELISA described in the Experimental section. The pre-normalized levels of FT in the untreated cells were 157p16 ng/mg and 39p6 ng/mg protein for H-FT and L-FT respectively. The control levels varied among experiments within the ranges of 140-400 ng/mg and 30-150 ng/mg protein for H-FT and L-FT respectively. LIP levels were measured by the calcein method [15] and normalized to intracellular calcein. LIP levels in untreated cells were 1.5p0.002 µM (normalized to 100 %). Those values varied among experiments within the range of 0.08-0.14 µM. ROS production was determined by the carboxy-DCF method, subsequent to a 5 µM H 2 O 2 challenge, as described in the Experimental section. Its level in the untreated cells was 5.7p9.7i10 − 4 nM carboxy-DCF oxidized per s (normalized to 100 %). *Values for the ferritin antisense-transfected cells were significantly different from the values for untreated cells (P 0.01), as determined by Student's independent t test. †Values are given as percent of untreated cells and are expressed as meanspS.D. of three replicates of a representative experiment.
Transfection vector H-FT † L-FT † Normalized LIP † ROS production † Iron content ( µM)
None 100p10 100p19 100p0.14 100p0.14 1088p407 pRBG4 106p5 119p3 102p0.14 123p7 799p372 pRBG4jH-FT antisense 52p15* 220p32* 149p0.28* 646p68* 735p225 mock-transfected or untreated cells ( Figure 1A and Table 1 ). The reduction in H-FT level was comparable with that attained by treatment with the iron chelator deferoxamine (50 µM for 24 h) ( Figure 1A ). However, unlike deferoxamine, which reduces the protein levels of both H-FT and L-FT (results not shown), H-FT antisense transfections evoked an increase in L-FT (Table 1) , whereas H-FT levels were decreased. This indicates that the action of the antisense was not the result of a non-specific effect on the synthetic machinery of the cell. The blockage of H-FT expression by the H-FT antisense treatment was also assessed at the mRNA level. According to the RT-PCR analysis shown in Figure 1(B) , the transfection significantly reduced the mRNA level of H-FT normalized to that of the housekeeping gene L-7. We tentatively attribute the mode of repression of H-FT to a reduction in the corresponding mRNA levels.
Figure 2 Immunofluorescence of H-FT levels in K562 cells
Figure 3 LIP levels and ROS production in H-FT-repressed cells
(A) Determination of LIP in K562 cells. Following quenching of non-cell-associated calcein (CA) fluorescence by anti-CA antibodies (Abs), the permeable chelator salicylaldehyde isonicotinoyl hydrazone (SIH) was added, and LIP was determined as described in [15] Although substantial, the level of antisense repression of H-FT expression was not complete in the experimental conditions used. It was, therefore, of interest to ascertain whether the antisense affected the cells differentially. In order to address this issue, we used indirect immunofluorescence staining of cells with H-FT antibodies. All staining was confirmed to be cell-associated, by both phase-contrast and immunofluorescent microscopy, which showed co-localization of the FITC stain with the nuclear stain DAPI (results not shown). A quantitative analysis of the fluorescent intensity associated with transfected cells revealed a bimodal distribution : in two-thirds of the cells, the average intensity (in 0-256 scale) was 123p25, whereas in the remaining third it was 186p13. The latter corresponded to the average intensity obtained in non-transfected cells, whereas the former corresponded to the value obtained in transfected cells in which treatment with the primary anti-H-Ft antibody was omitted. The results agree with the possibility that H-FT was repressed only in that fraction of cells that was successfully transfected (Figure 2 ). Therefore the cellular parameters affected by the antisense transfection should be regarded as underestimates when expressed as means of the whole cell population.
Effects of H-FT repression on LIP and ROS formation
The effects of the H-FT antisense on the expression of H-FT and L-FT could be attributed to two possible mechanisms : one involving a direct, but opposing, action of antisense on each subunit, and the other based on the specific repression of the H-FT subunit, indirectly leading to increased L-FT synthesis by increasing the LIP, and thereby decreasing the IRP activity. Our results (Table 1 ) support the second mechanism. The experimental steady-state levels of LIP were significantly higher in the H-FT antisense-transfected cells as compared with either untreated cells or mock-transfected cells (Table 1 and Figure  3A ). These effects are consistent with the reduction in L-FT observed in cells overexpressing H-FT in which LIP was reduced [13, 20] . In parallel, higher ROS production was observed after the H-FT antisense-transfected cells were challenged with H # O # (5 µM) ( Figure 3B ). This result indicates that the up-modulation of LIP by the H-FT antisense transfection is associated with a catalytic (labile) reservoir. Although the LIP levels in cells with different H-FT levels were significantly different, their total iron content was apparently similar (Table 1) . It should be emphasized that LIP is the metabolically active cellular iron, even though it constitutes only a minor fraction ( 1 %) of the total cellular iron (results not shown and [12] ). Ferritin repression increases the labile iron pool
Effects of H-FT repression on TfR
The possibility that the rise in LIP evoked by H-FT repression led to IRP inactivation [21, 22] , and thereby increased L-FT expression, was also assessed in terms of TfR expression, i.e. TfR-mediated iron uptake ( Figure 4A ) and TfR surface expression ( Figure 4B ). H-FT repression, like addition of an iron salt (ferric ammonium citrate, 20 µM for 24 h), repressed both transferrin-Fe uptake and TfR expression. This supports the notion that the repressive effect of the H-FT antisense on TfR was via up-modulation of the LIP.
DISCUSSION
We have used transient transfection of an H-FT antisense fragment in order to directly assess H-FT's role as a regulator of LIP and ROS formation. It has been generally assumed that ferritin protein expression is regulated translationally by IRP activity, which is controlled by the LIP levels [21, 22] . However, ferritin has also been proposed to function as an ' active ' modulator of the LIP by IRP-independent mechanisms associated with transcriptional regulation [5, 23, 24] . In order to ascertain that ferritin expression can actively affect the LIP, we aimed to set up experimental conditions that allowed ferritin levels to be monitored independently of the LIP. We achieved that goal by specifically reducing H-FT expression, using transient transfection with an H-FT antisense fragment ( Figure 1A and Table 1 ). The reduction in the average cellular H-FT levels was substantial (approx. 50 %). However, only about two-thirds of the cells underwent transfection (Figure 2 ). Thus the actual changes evoked in the transfected sub-population are 25 % higher than the average value for the entire population, representing 75 % reduction in H-FT in the transfected sub-population.
The reduction in H-FT levels evoked a concomitant increase in the LIP, whether measured directly with a fluorescent sensor or indirectly by its capacity to promote ROS formation or induce synthesis of the L-FT subunit ( Table 1) . The mechanism by which repression of H-FT affected the LIP differed from that of chelators which act on the LIP-IRP feedback loop. Thus unlike iron chelation by deferoxamine, which reduces both ferritin subunit levels via reduction in the LIP and activation of IRP, the H-FT antisense transfection led to an increase in the steady-state LIP and associated parameters. Moreover, the fact that the transfected cells expressed reduced H-FT content, despite their demonstrably higher LIP levels, indicates that repression of H-FT by antisense-mediated transfection overcame the cell IRP regulatory capacity [21, 22] .
These results complement studies in which ferritin was overexpressed independently of LIP, using cells stably transfected with H-FT mutated in its iron-responsive element [12] [13] [14] . In those studies, overexpression of H-FT led to a concomitant decrease in LIP, supporting the presumed role of ferritin in controlling LIP levels. Taken as a whole, the modulation of H-FT expression by transfections with H-FT constructs provides experimental support for the active role of ferritin in both upand down-regulation of LIP and ROS generation. This active role of ferritin has been implied in different aspects of cell growth [25] , such as protection against oxidative stress [26] [27] [28] , intracellular pathogens [29] [30] [31] , and in various inflammatory conditions [30] [31] [32] ]. An active role of H-FT in the control of LIP levels provides an experimental framework for rationalizing the observed oncogene-mediated transcriptional repression of H-FT [1] [2] [3] [4] [5] [6] 33] . Such a repression has been hypothesized to support cell proliferation, presumably by making more LIP available for accelerated cell growth. However, this study provides the first experimental evidence linking the presumed rise in LIP to H-FT repression. Unfortunately the delayed expression of the ferritin antisense in transfected cells hampered the assessment of the role of ferritin in accelerated cell growth. This subject is currently under investigation with the aid of antisense oligodeoxynucleotides that allow long-term studies in culture (O. Kakhlon, Y. Gruenbaum and Z. I. Cabantchik, unpublished work).
